PERCEPTIVE ADVISORS LLC
Q4 2021 13F-HR/A Holdings
Net value change ($000)
-407,426
(-5.9%)
New positions
21
Sold out positions
17
Turnover %
19.7%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q3 2021
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| LIANY | 346,931 | NEW |
| BMRN | 104,253 | NEW |
| MGTX | 73,374 | 80.1% |
| CRNX | 63,264 | 75.8% |
| BELLUS Health Inc. | 61,544 | NEW |
| FOLD | 53,119 | 20.9% |
| APLS | 48,366 | 238.6% |
| Prometheus Biosciences, Inc. | 46,876 | 59.7% |
| ARENA PHARMACEUTICALS INC | 46,470 | NEW |
| XENE | 44,437 | 143.8% |
Top Reduces (Value $000, Stocks/ETFs)
| BBIO | -244,660 | -67.3% |
| Landos Biopharma, Inc. | -145,726 | -67.1% |
| Mirati Therapeutics, Inc. | -117,628 | -19.6% |
| IOVA | -89,995 | -31.8% |
| Invitae Corp | -87,354 | -78.3% |
| AVIR | -79,208 | -100.0% |
| VAC | -48,719 | -28.5% |
| ALDX | -47,340 | -54.4% |
| BEAM | -46,780 | -100.0% |
| ZYMEWORKS INC | -46,551 | -43.6% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
15,064
(0.2% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|